Allied Market Research published a report, titled, “Compounding Pharmacies Market by Therapeutic Area (Pain Management, Hormone Replacement Therapy, Dermal Disorders, Nutritional Supplements, Others), by Route of Administration (Oral, Topical, Others), by Sterility (Non-Sterile Compounding Drugs, Sterile Compounding Drugs): Global Opportunity Analysis and Industry Forecast, 2021-2031.” According to the report, the global compounding pharmacies industry was estimated at $8.12 billion in 2021, and is anticipated to hit $14.84 billion by 2031, registering a CAGR of 6.2% from 2022 to 2031. The report offers an explicit analysis of the changing market trends, top segments, key investment pockets, value chain, competitive scenario, and regional landscape.
“Increase in prevalence of chronic disease. high adoption of non-sterile medication, increase in old age population and improved life expectancy, along with increasing awareness about compounding medications fuel growth of the compounding pharmacies market. ”
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 (245 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐅𝐢𝐠𝐮𝐫𝐞𝐬): https://www.alliedmarketresearch.com/request-sample/12285
𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲-
Advanced Pharmacy, Athenex Pharma Solutions, B. Braun Melsungen AG, Dougherty’s Pharmacy, Inc., Fresenius SE and Co. KGaA, Institutional pharmacy solutions, ITC compounding pharmacy, McGuff Companies, Inc., Nephron pharmaceuticals, New Compounding Pharma, Olympia Compounding Pharmacy, Panacea Biomatx Inc (Triangle Compounding Pharmacy), Pencol compounding pharmacy, Perrigo Company Plc (Fagron), Rx express compounding pharmacy, RX3 compounding pharmacy, Valor Compounding Pharmacy
◾ Amidst the global health crisis, the demand for compounded medication witnessed a steep incline in 2021, due to increased demand for quite a lot of
medications for the treatment of Covid-19.
◾ Reduced manufacturing activities due to restrictions and shortage of commercially available drugs gave way to increased adoption of a compounded
◾ Moreover, FDA gave out a temporary guidance policy to the federal facilities and state-licensed pharmacies, comprising hospital pharmacies and
compounding pharmacies that are not listed with FDA as outsourcing facilities for compounding certain medication for hospitalized patients, owing to
shortage of generic drugs.
𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭 𝐨𝐧 𝐂𝐎𝐕𝐈𝐃-19? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/request-for-customization/12285?reqfor=covid
𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧 :
⮞ North America (U.S., Canada, Mexico)
⮞ Europe (Italy, Spain, Rest of Europe, Germany, France, UK)
⮞ Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
⮞ LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
The key factors driving the growth of compounding pharmacy market are increase in prevalence of chronic diseases, high acceptance of non-sterile drugs, increase in elderly population, and higher life expectancy. Moreover, growing drug failure rate, increase in popularity of personalized medicine, and massive drug shortages across the globe are some compounding pharmacies market trends further expected to boost the market growth during the forecast period. However, increase in restrictions on manufacturing of complex formulations is likely to hamper the growth of compounding pharmacies market during the forecast period. Conversely, the growth potential of emerging economies is expected to provide ample opportunities for the market growth during the forecast period.
By therapeutic area, the pain management segment dominated the market in 2021 and is expected to remain dominant during the forecast period. This can be attributed to the increasing geriatric population, rising number of surgical procedures, and rise in healthcare expenditure. On the other hand, the “other” segment is expected to witness the fastest market growth during the forecast period, owing to increase in neurological disorders and cancer cases.
𝐆𝐥𝐨𝐛𝐚𝐥 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝𝐢𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐢𝐞𝐬 𝐛𝐲 𝐑𝐞𝐠𝐢𝐨𝐧
Region wise, North America has the highest compounding pharmacies market share share in compounding pharmacies industry in 2021 registering a CAGR of 5.9% during the forecast period. This is attributed to the well-established healthcare system, increase in number of geriatric patients, and supportive reimbursement policies in healthcare system and increasing number of healthcare facilities offering compounding pharmacy products. Asia pacific is projected to register the highest CAGR of 7.3% during the forecast period. The presence of a large population base, increasing per capita income, growing medical tourism industry, and rising public awareness regarding benefits of compounding medications are the key driving factors that boost the growth of the market in the region.
𝐅𝐑𝐄𝐐𝐔𝐄𝐍𝐓𝐋𝐘 𝐀𝐒𝐊𝐄𝐃 𝐐𝐔𝐄𝐒𝐓𝐈𝐎𝐍𝐒?
Q1. Which is the most influencing segment growing in the Compounding Pharmacies Market report?
Q2. What are the key trends in the Compounding Pharmacies Market report?
Q3. What is the total market value of Compounding Pharmacies Market report ?
Q4. What would be forecast period in the market report?
Q5. Which are the top companies hold the market share in compounding pharmacies market?
Q6. What is the market value of Compounding Pharmacies Market in 2031?
Q7. Which is base year calculated in the Compounding Pharmacies Market report?
𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/checkout-final/5a482462fd1e78869c9aca32a6e9094a
Trending Healthcare Reports :
⮞ Hip Replacement Market https://www.alliedmarketresearch.com/hip-replacement-market-A17084
⮞ Tendon Repair Market https://www.alliedmarketresearch.com/tendon-repair-market-A17088
⮞ Radiation Oncology Market https://www.alliedmarketresearch.com/radiation-oncology-market-A18438
⮞ Arthroscopy Devices Market https://www.alliedmarketresearch.com/arthroscopy-devices-market